| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Denali Therapeutics Inc. | Director | Common Stock | 782K | $12.9M | $16.44 | Jun 3, 2025 | Indirect |
| Guardant Health, Inc. | Director | Common Stock | 18.6K | $1.8M | $96.72 | Nov 30, 2025 | Direct |
| Denali Therapeutics Inc. | Director | Common Stock | 31.8K | $523K | $16.44 | Jun 3, 2025 | Direct |
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 30K | $111K | $2.08 | Jun 5, 2025 | Direct |
| Guardant Health, Inc. | Director | Restricted Stock Units | 1.08K | $98.3K | $42.47 | Nov 30, 2025 | Direct |
| Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 51.8K | Jun 16, 2023 | Direct | ||
| Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 18.1K | Jun 3, 2025 | Direct | ||
| Guardant Health, Inc. | Director | Stock Option (Right to Buy) | 6.83K | Jun 18, 2025 | Direct |